01 October 2012: Clinical Research
Expression of estrogen receptors α and β in paratesticular tissues in boys operated on for unilateral cryptorchidism between the 1st and 4th years of life
Adam Hermanowicz ABDEF , Ewa Matuszczak BEF , Wojciech Debek BDE , Ewa Dzienis-Koronkiewicz B , Marta Komarowska BEF , Marzanna Oksiuta B , Jolanta Kowalewska CE , Robert Milewski C
DOI: 10.12659/MSM.883490
Med Sci Monit 2012; 18(10): CR630-634
Background
There is growing evidence from clinical and epidemiological studies for an increasing incidence of male reproductive disorders (ie, cryptorchidism). The etiology of undescended testis is still surrounded by much controversy. Approximately 90% of cases of cryptorchidism occur spontaneously or from unknown causes. The process of descending of the testes is one of the most important factors in spermatogenesis in mature testis. This suggests that environmental or lifestyle, rather than genetic, factors are plausible causes [1]. Indeed, mutations in the Insl3 or LGR8
A broad expression of estrogen receptors (ERs) in the testis suggests an important role of estrogens in regulating testicular cell function and reproductive events. Estrogen is a key regulator of growth and differentiation in a broad range of target tissues – the reproductive tract, mammary gland, and the central nervous and skeletal systems [3,4]. Estrogen is also known to be involved in many pathological processes such as breast and endometrial cancer, and osteoporosis [5,6]. The major source of endogenous estrogen in men is adipose tissue, but the receptor proteins (ERα and ERβ) are localized in most cell types in the testis in concordance with a physiological role for estrogen in testicular development and function [7]. The presence of an estrogen binding receptor protein – ERα – was first reported in 1962 [8]. In 1996, an additional estrogen receptor – ERβ – was cloned from rat prostate [9]. ERβ were cloned from many species, including humans [10,11]. ERα and ERβ belong to the superfamily of nuclear receptors and specifically to the family of steroid receptors that act as ligand-regulated transcription factors [12,13]. ERα and ERβ have different biological functions and different phenotypes [14]. Abnormal estrogen action has been implicated as a possible cause for sporadic cryptorchidism in humans [15]. Animal studies support the human correlations. In mice,
In the present study we assessed expression of estrogen receptors α and β in paratesticular tissues in a group of boys with and without cryptorchidism. We evaluated the karyotypes of these boys, as well as the position, morphology and diameters of the undescended testes.
Material and Methods
STUDY POPULATION:
Fifty boys aged 1–4 years (median=2,4 y.) with unilateral cryptorchidism, and without previous human chorionic gonadotropin treatment, were evaluated. All of them underwent orchidopexy in 2010. Abnormal karyotype, as well as the presence of any endocrine disorders, and hormonal drugs intake, constituted grounds for exclusion from the study. Prior to their orchidopexy, all of the subjects had their karyotypes (to exclude chromosomal abnormalities) evaluated. During the actual orchidopexy, the gubernaculum samples were collected, the position and morphology of the testes were evaluated, and their diameters were measured.
CONTROL GROUP:
Fifty healthy boys aged 1–4 years (median=2,1 y.), admitted to the Pediatric Surgery Department for planned inguinal hernia repairs in 2010, served as controls. All boys in the control group had their testes in the scrotum. Their karyotypes were also determined prior to their procedures. The samples of the diverticulum of the peritoneum were collected during herniotomy.
Data were collected from patients admitted to the Pediatric Surgery Department for either a planned orchidopexy or hernia repair. All parents of the patients gave informed consent for both clinical and histological follow-up. Tissue samples – gubernaculum and diverticulum of peritoneum – were collected during planned surgeries. Measurements of expression of ER α ER β receptors were preformed using monoclonal mouse antibodies against human receptor α, (Monoclonal Mouse Anti-Human Estrogen Receptor α, clone 1D5, of IgG1 kappa isotype), and β (Monoclonal Mouse Anti-Human Estrogen Receptor β clone PPG5/10), respectively. In further stages we used anti-mouse antibody combined with biotin and peroxidase, and visualized by using FLEX+ Mouse, High pH (K8002/K8012) for alpha receptors and DAKO LSAB+/HRP, (K 0679) and DAKO EnVision+/HRP (K4004 and K4006) for beta. Sections were counter-stained with haematoxylin. The results were expressed as the percentage of positive cells with a strong positive receptor staining and labeled as follows: negative (−) with ≤10% of positive cells, positive (+) with 11% to 50% of positive cells, and highly positive (++) with ≥51% positive cells, in a set of 10 random fields under 20× magnification.
The study was approved by the local Ethics Committee as an audit of a clinically agreed-upon protocol of investigation and treatment.
STATISTICAL ANALYSES:
Statistical analyses were carried out using Statistica 10.0 StatSoft. To compare observed data we used chi-square test and Pearson’s correlation. P values less than 0.05 were considered significant.
Results
There was no statistically significant difference in the age distribution of the 2 groups. All boys had karyotypes 46XY. The undescended testes were mainly localized in the inguinal canal (n=46), but in 2 of the instances were located in the external ring of the inguinal canal, while 2 more subjects had theirs in the abdominal cavity. The overall lengths of the undescended testes differed from 0.8 cm to 2 cm, and in most cases were found to be smaller in comparison to the testes positioned normally (mean 1 cm and mean 1.5 cm, respectively). In 9 of the cases of cryptorchidism, the testes had different shape (drop-like), and the epididymides were small, dysplastic and separated from the testis.
We measured expression of Erα and ERβ in paratesticular tissues: in the mesothelial layer, stromal cells, endothelial layer, and smooth muscle layer.
In the mesothelial layer there was a statistically significant (p=0.04) difference in the expression of ERα. The expression of ERα was higher in undescended testes. In 71% of the cases of the cryptorchidism we found a high expression of the ERα. In the inguinal hernia group the strong expression (++) were found only in 18% of the cases. We also found that in 32% of the inguinal hernia patients there was no ERα expression at all. There was no difference in the expression of ERβ in the mesothelial layer between the 2 groups.
In the stromal cell layer there was statistically significant higher expression of ERβ (p<0.05) in undescended testes. In these cases, 62% of patients with undescended testes had a strong ERβ expression. There was no statistically significant difference between expressions of ERα in stromal cell layer between the 2 groups.
In the endothelial layer there was no statistically significant difference in expression of ERα and ERβ between the 2 groups. In the both groups, expression of the ERα and ERβ in most of the cases were only positive (+).
In the smooth muscle layer, there was no expression of ERα in both groups. The expression of ERβ in the smooth muscle layer was nearly identical in the group of boys with inguinal hernia and in boys with unilateral cryptorchidism: no expression in 7 and 10 cases, normal expression in 32 and 34 cases, and high expression in 11 and 6 cases, respectively.
Figures 1–4 shows the expression of the alpha and beta receptors in the particular layers in both groups.
Discussion
In this study we focused on ERα and ERβ expression in paratesticular tissues of cryptorchid testes. There are few reports about the relationship between ERs and spermatogenic failure in cryptorchidism [37,38]. It was shown that testosterone level was lower and estradiol level was higher in the cryptorchid than in normal testes by radioimmunological analysis of testicular tissue [37,39]. Studies in rodents have revealed that ERα is predominantly expressed in the pituitary, uterus, ovary, mammary gland, testis, epididymis and kidney; whereas ERβ is predominant in hypothalamus, prostate, lung, and bladder [40]. In our study we found expression of ERα and ERβ in the mesothelial layer, stromal cells, and the endothelial layer of paratesticular tissues of normal and undescended testes. In the smooth muscle layer there was no expression of ERα and nearly identical expression of ERβ. Mizuno et al showed increased expression of ERα in cryptorchid testes, suggesting that estradiol level was increased in the cryptorchid testes because estrogens upregulate the expression of the ERα gene in most mammalian tissues [37,41]. We also observed higher expression of ERα in the mesothelial layer of paratesticular tissues of undescended testes. In our study we found also higher expression of ERβ in the stromal cell layer of paratesticular tissue in undescended testes. Excess intratesticular estrogens inhibit spermiation [37,42]. An estrogen excess can decrease testicular androgen production by lowering the activity of steroidogenic enzymes that convert progesterone to testosterone [43]. The estrogens also act as permanent organizing agents during male fetal development, and as reversible regulators in adult life. Strauss et al. have mentioned the importance of androgen-estrogen balance for male fertility and reproductive tract function. Using transgenic male mice that express human aromatase, they demonstrated that chronic imbalance in the androgen-estrogen ratio leads to severe abnormalities in the development, structure, and function of mouse Leydig cells [37,44]. In vertebrates, estradiol also inhibits Leydig cell precursor development. By reducing the number or volume of Leydig cells in the developing testis, testosterone production is compromised, with impaired masculinization (undescended testis, hypospadias) and spermatogenic progression [45]. In estrogen-treated mice, the intra-abdominal position of the testes is due to the absence of Insl3 hormone, but not of androgens. Estrogens block the first phase of testicular descent (transabdominal descent), which is controlled hormonally by Insl3 [30]. As a possible alternative mechanism, other authors suggested that
Unilateral cryptorchidism carries an increased risk of infertility in adulthood [32]. Up to 30% of men operated on in childhood for unilateral cryptorchidism are likely to be subfertile in later life [49]. Men who undergo an operation for bilateral cryptorchidism are more affected – up to 54% are infertile according to their semen and hormonal analysis [50]. The position of the testes at the time of orchidopexy is also important. In fact, a lack of fertility has been reported in men who underwent bilateral abdominal orchidopexy in childhood [51]. In our study, mean diameters of undescended testes were smaller in comparison to the normally developing ones (1×0.5 cm and 1.5×0.8 cm, respectively).
Testicular size and sperm density are positively correlated to germ-cell status in the cryptorchid testes in childhood [52]. Estrogenic exposure may, through ERα, inhibit the activation of Insl3 and steroidogenic genes in fetal Leydig cells.
If estrogen underlies sporadic cryptorchidism, then it is likely that these effects are mediated by smaller doses localized to the correct target tissue at the precise time, thus achieving maximal effect. It may be possible that a small excess of free estradiol at the right developmental stage may have a strong impact on testicular descent [30]. The main argument against estrogens as potential factors in impaired testicular descent is the lack of persistent Müllerian structures in affected humans [30].
Conclusions
Our results show that estrogens are potential mediators of cryptorchidism, and the inhibitory effects of estrogens on testicular descent may be mediated via ERα and ERβ.
References
1. Cederroth CR, Schaad O, Descombes P, Estrogen receptor alpha is a major contributor to estrogen-mediated fetal testis dysgenesis and cryptorchidism: Endocrinology, 2007; 148; 5507-19, pmid: 17673513
2. Baker LA, Nef S, Nguyen MT, The insulin-3 gene: lack of a genetic basis for human cryptorchidism: J Urol, 2002; 167; 2534, pmid: 11992081
3. Couse JF, Korach KS, Estrogen receptor null mice: what have we learned and where will they lead us?: Endocr Rev, 1999; 20; 358-417, pmid: 10368776
4. Pettersson K, Gustafsson JA, Role of estrogen receptor β in estrogen action: Annu Rev Physiol, 2001; 63; 165-92, pmid: 11181953
5. Henderson BE, Ross R, Bernstein L, Estrogens as a cause of human cancer: the Richard and Hinda Rosenthal Foundation award lecture: Cancer Res, 1988; 48; 246-53, pmid: 2825969
6. Horowitz MC, Cytokines and estrogen in bone: anti-osteoporotic effects: Science, 1993; 260; 626-27, pmid: 8480174
7. Akingbemi BT, Estrogen regulation of testicular function: Rep Biol Endocrinol, 2005; 3; 51
8. Jensen EV, Jacobson HI, Basic guides to the mechanism of estrogen action: Rec Prog Horm Res, 1962; 18; 387-414
9. Kuiper GG, Gustafsson JA, The novel estrogen receptor-β subtype: potential role in the cell- and promoter-specific actions of estrogens and anti-estrogens: FEBS Lett, 1997; 410; 87-90, pmid: 9247129
10. Mosselman S, Polman J, Dijkema R, ER β: identification and characterization of a novel human estrogen receptor: FEBS Lett, 1996; 392; 49-53, pmid: 8769313
11. Tremblay GB, Tremblay A, Copeland NG, Cloning, chromosomal localization, and functional analysis of the murine estrogen receptor β: Mol Endocrinol, 1997; 11; 353-65, pmid: 9058381
12. Beato M, Gene regulation by steroid hormones: Cell, 1989; 56; 335-44, pmid: 2644044
13. Evans RM, The steroid and thyroid hormone receptor superfamily: Science, 1988; 240; 889-95, pmid: 3283939
14. Zhao C, Dahlman-Wright K, Gustafsson JA, Estrogen receptor beta: an overview and update: Nucl recept Signal, 2008; 6; e003, pmid: 18301783
15. Gill WB, Schumacher GF, Bibbo M, Association of diethylstilbestrol exposure in utero with cryptorchidism, testicular hypoplasia and semen abnormalities: J Urol, 1979; 122; 36-39, pmid: 37351
16. Grocock CA, Charlton HM, Pike MC, Role of the fetal pituitary in cryptorchidism induced by exogenous maternal oestrogen during pregnancy in mice: J Reprod Fertil, 1988; 83; 295-300, pmid: 2899644
17. Hadziselimovic F, Girard J, Pathogenesis of cryptorchidism: Horm Res, 1977; 8; 76-83, pmid: 20399
18. Hutson JM, Case of a testis prolapsed through a skin defect in the upper scrotum: J Pediatr Surg, 1992; 27; 1257, pmid: 1432544
19. Khan SA, Ball RB, Hendry WR, Effects of neonatal administration of diethylstilbestrol in male hamsters: Disruption of reproductive function in adults after apparently normal pubertal development: Biol Reprod, 1998; 58; 137-42, pmid: 9472934
20. Heyns CF, Hutson JM, Historical review of theories on testicular descent: J Urol, 1995; 153; 754-67, pmid: 7861531
21. Dorrington JH, Armstrong DT, Follicle stimulating hormone stimulates estradiol 17b synthesis in cultured Sertoli cells: Proc Natl Acad Sci USA, 1975; 72; 2677-81, pmid: 170613
22. Pomerantz DK: Biol Reprod, 1980; 23; 948-54, pmid: 6781544
23. Kelch RP, Jenner MR, Weinstein R, Estradiol and testosterone secretion in human, simian and canine testes, in males with hypogonadism and in male pseudohermaphrodite with the feminizing testes syndrome: J Clin Invest, 1972; 51; 824-30, pmid: 4259253
24. Nef S, Parada LF, Cryptorchidism in mice mutant for Insl3: Nat Genet, 1999; 22; 295-99, pmid: 10391220
25. Zimmermann S, Steding G, Emmen JM, Targeted disruption of the Insl3 gene causes bilateral cryptorchidism: Mol Endocrinol, 1999; 13; 681-91, pmid: 10319319
26. Hutson JM, Baker M, Terada M, Hormonal control of testicular descent and the cause of cryptorchidism: Reprod Fertil Dev, 1994; 6; 151-56, pmid: 7991782
27. Hutson JM, Hasthorpe S, Heyns CF, Anatomical and functional aspects of testicular descent and cryptorchidism: Endocr Rev, 1997; 18; 259-80, pmid: 9101140
28. Hutson JM, Hasthorpe S, Testicular descent and cryptorchidism: the state of the art in 2004: J Pediatr Surg, 2005; 40; 297-302, pmid: 15750918
29. Adham IM, Agoulnik AI, Insulin-like 3 signalling in testicular descent: Int J Androl, 2004; 27; 257-65, pmid: 15379965
30. Nef S, Shipman T, Parada LF, A molecular basis for estrogen-induced cryptorchidism: Dev Biology, 2000; 224; 354-61
31. Overbeek PA, Gorlov IP, Sutherland RW, A transgenic insertion causing cryptorchidism in mice: Genesis, 2001; 30; 26-35, pmid: 11353515
32. Ferlin A, Bogatcheva NV, Gianeselto L, Insulin-like factor 3 gene mutations in testicular dysgenesis syndrome: clinical and functional characterization: Mol Hum Reprod, 2006; 12; 401-6, pmid: 16687567
33. Roh J, Virtanen H, Kumagai J, Lack of LGR8 gene mutation in Finnish patients with a family history of cryptorchidism: Reprod Biomed Online, 2003; 7; 400-6, pmid: 14656401
34. Harnaen EJ, Na AF, Shenker NS, The anatomy of the cremaster muscle during inguinoscrotal testicular descent in the rat: J Pediatr Surg, 2007; 42; 1982-87, pmid: 18082692
35. Foresta C, Zuccarello D, Garolla A, Ferlin A, Role of hormones, genes and environment in human cryptorchidism: Endocrine Reviews, 2008; 29; 560-80, pmid: 18436703
36. Nation TR, Balic A, Southwell BR, The hormonal control of testicular descent: Ped Endocrinol Rev, 2009; 7; 22-31
37. Mizuno K, Kojami Y, Kurosawa S, Altered expression and localization of estrogen receptors Ralpha and beta In the testes of a cryptorchid rat model: Urology, 2011; 77; 251.e1-e6, pmid: 20951417
38. Li EZ, Li DX, Hang SQ, 17-beta-estradiol stimulates proliferation of spermatogonia In experimental cryptorchid mice: Asian J Androp, 2007; 9; 659-67
39. Hejmej A, Bilińska B, The effects of cryptorchidism on the regulation of steroidogenesis and gap junctional communication In equine testes: Endokrynol Pol, 2008; 59; 112-18, pmid: 18465685
40. Routledge EJ, White R, Parker MG, Sumptem JP, Differential effects of xenoestrogens on coactivator recruitment by estrogen receptor ER-α and ER-β: J Biol Chem, 2000; 275; 35986-93, pmid: 10964929
41. Robertson JA, Parnell Y, Lindhal LS, Ing NH, Estradiol up-regulates estrogen receptor Messenger ribonucleic acid In endometrial carcinoma cells by stabilizing the message: J Mol Endocrinol, 2002; 29; 125-35, pmid: 12200234
42. D’Souza R, Pathak S, Upadhyay R, Disruption of tubulobulbar complex by high intratesticular estrogens leading to failed spermiation: Endocrinology, 2009; 150; 1861-69, pmid: 19095743
43. Smith EP, Boyd J, Frank GR, Estrogen resistance caused by a mutation In the estrogen-receptor gene In a man: N Engel J Med, 1994; 331; 1056-61
44. Strauss L, Kallio J, Desai N, Increased exposure to estrogens disturbs maturation, steroidogenesis, and cholesterol homeostasis via estrogen receptor Ralpha In adult Mouse Leydig cells: Endocrinology, 2009; 150; 2865-72, pmid: 19196801
45. Hess RA, Buncik D, Lee KH, A role for oestrogens In the male reproductive system: Nature, 1997; 390; 509-12, pmid: 9393999
46. Vidaeff AC, Sever LE: Reproductive Toxicology, 2005; 20; 5-20, pmid: 15808781
47. O’Donnell L, Robertson KM, Jones ME, Simpson ER, Estrogen and spermatogenesis: Endor Rev, 2000; 22; 289-318
48. Delbes G, Levacher C, Duquenne C, Endogenous estrogens inhibit Mouse fetal Leydig cell development via estrogen receptor α: Endocrinology, 2005; 146; 2454-61, pmid: 15661855
49. Thorup J, MaLachlan R, Cortes D, What is new in cryptorchidism and hypospadias – a critical review on the testicular dysgenesis hypotesis: J Pediatr Surg, 2010; 45; 2074-86, pmid: 20920735
50. Lee PA, Coughlin MT, Fertility after bilateral cryptorchidism. Evaluation by paternity, hormone and semen data: Horm Res, 2001; 55; 28-32, pmid: 11423739
51. Taran I, Elder JS, Results of orchiopexy for the undescended testis: World J Urol, 2006; 24; 231-39, pmid: 16676187
52. Hadziselimovic F, Hoecht B, Testicular histology related to fertility outcome and postpubertal hormone status in cryptorchidism: Klin Pädiatr, 2008; 220; 302-7, pmid: 18401814
In Press
Clinical Research
Institutional and Regional Variations in Access to Clinical Trials and Next-Generation Sequencing in Turkis...Med Sci Monit In Press; DOI: 10.12659/MSM.951027
Clinical Research
Low-Intensity Blood Flow-Restricted Multi-Joint Exercise Improves Muscle Function in Patients With Patellof...Med Sci Monit In Press; DOI: 10.12659/MSM.950516
Review article
Musculoskeletal Ultrasound and MRI in the Evaluation of Chemotherapy-Induced Peripheral Neuropathy: A ReviewMed Sci Monit In Press; DOI: 10.12659/MSM.951283
Clinical Research
Sensory Processing, Dissociation, and Affective Symptoms in Misophonia: A Cross-Sectional Study of 35 AdultsMed Sci Monit In Press; DOI: 10.12659/MSM.950938
Most Viewed Current Articles
17 Jan 2024 : Review article 10,187,196
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
13 Nov 2021 : Clinical Research 3,708,487
Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...DOI :10.12659/MSM.932788
Med Sci Monit 2021; 27:e932788
14 Dec 2022 : Clinical Research 2,341,643
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research 706,524
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387






